J Pediatr Infect Dis 2011; 06(04): 269-271
DOI: 10.3233/JPI-2012-0334
Georg Thieme Verlag KG Stuttgart – New York

Rapidly fatal reactive hemophagocytosis syndrome associated with visceral leishmaniasis

Lokesh Kumar Tiwari
a   Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India
,
Devi dayal
a   Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India
,
Reena Das
a   Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India
,
Sudhanshu Grover
a   Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India
› Author Affiliations

Subject Editor:
Further Information

Publication History

17 May 2011

26 July 2011

Publication Date:
28 July 2015 (online)

Abstract

Hemophagocytosis syndrome secondary to visceral leishmaniasis (VL) is rare. The diagnosis is likely to be missed because of its clinical presentation similar to VL. Because Leishmaniasis is endemic in many states of India, primary treating physicians needs to be sensitized about the existence of this potentially fatal but treatable entity. Further, it is important to differentiate infection associated reactive hemophagocytosis syndrome (RHS) from primary hemophagocytosis to avoid unnecessary and potentially harmful cytotoxic therapy in infection associated hemophagocytosis. In this report, a young boy who developed accelerated RHS secondary to VL is presented. He succumbed to acute haematological complications of RHS while undergoing procedures for establishing the diagnosis of his primary illness.